THOMAS LLOYD to United States
This is a "connection" page, showing publications THOMAS LLOYD has written about United States.
Connection Strength
0.038
-
Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2023 10; 22(10):900-911.
Score: 0.017
-
Internal grant review to increase grant funding for junior investigators. Ann Neurol. 2017 10; 82(4):497-502.
Score: 0.011
-
Mortality and Causes of Death in Patients with Sporadic Inclusion Body Myositis: Survey Study Based on the Clinical Experience of Specialists in Australia, Europe and the USA. J Neuromuscul Dis. 2016 03 03; 3(1):67-75.
Score: 0.010